000 | 01771 a2200493 4500 | ||
---|---|---|---|
005 | 20250516155412.0 | ||
264 | 0 | _c20140204 | |
008 | 201402s 0 0 eng d | ||
022 | _a1875-8894 | ||
024 | 7 |
_a10.3233/PRM-130242 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCohran, Valeria | |
245 | 0 | 0 |
_aOral risedronate sodium improves bone mineral density in non-ambulatory patients: a randomized, double-blind, placebo controlled trial. _h[electronic resource] |
260 |
_bJournal of pediatric rehabilitation medicine _c2013 |
||
300 |
_a85-93 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAbsorptiometry, Photon |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
650 | 0 | 4 |
_aCerebral Palsy _xpathology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCollagen Type I _xblood |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aEtidronic Acid _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLumbar Vertebrae _xdiagnostic imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOsteocalcin _xblood |
650 | 0 | 4 |
_aPeptides _xblood |
650 | 0 | 4 | _aRisedronic Acid |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aCassedy, Amy | |
700 | 1 | _aHawkins, Andre | |
700 | 1 | _aBean, Judy | |
700 | 1 | _aHeubi, James | |
773 | 0 |
_tJournal of pediatric rehabilitation medicine _gvol. 6 _gno. 2 _gp. 85-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3233/PRM-130242 _zAvailable from publisher's website |
999 |
_c22869074 _d22869074 |